SEC Form 4/A · accession 0001017491-16-000175
SEELOS THERAPEUTICS, INC. · SEEL
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
This is an amendment (Form 4/A). It replaces an earlier filing for the same period.
Reporting owner
Brian Dorsey
Officer — SVP, Chief Development Officer
Period of report
Apr 25, 2016
Accepted (ET)
May 20, 2016 · 6:17 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001017491
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | Apr 25, 2016 | A | 0 | — | A | 51,891 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Amended to correct the number of restricted stock units issued pursuant to action of the Issuer's board of directors to void the award.
- F2Not applicable.